BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24784698)

  • 1. Inhaled budesonide and oral dexamethasone prevent acute mountain sickness.
    Zheng CR; Chen GZ; Yu J; Qin J; Song P; Bian SZ; Xu BD; Tang XG; Huang YT; Liang X; Yang J; Huang L
    Am J Med; 2014 Oct; 127(10):1001-1009.e2. PubMed ID: 24784698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled budesonide prevents acute mountain sickness in young Chinese men.
    Chen GZ; Zheng CR; Qin J; Yu J; Wang H; Zhang JH; Hu MD; Dong JQ; Guo WY; Lu W; Zeng Y; Huang L
    J Emerg Med; 2015 Feb; 48(2):197-206. PubMed ID: 25294611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide Versus Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS; Pomeranz D; Burns P; Phillips C; Cheffers M; Evans K; Jurkiewicz C; Juul N; Hackett P
    Am J Med; 2018 Feb; 131(2):200.e9-200.e16. PubMed ID: 28668540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of inhaled budesonide on prevention of acute mountain sickness during emergent ascent: a meta-analysis of randomized controlled trials.
    Nepal G; Yadav JK; Rehrig JH; Bhandari N; Baniya S; Ghimire R; Mahotra N
    BMC Emerg Med; 2020 May; 20(1):38. PubMed ID: 32404064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
    Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
    Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial.
    Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
    Chest; 2018 Oct; 154(4):788-797. PubMed ID: 29909285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide, but not dexamethasone, blunted the response of aldosterone to renin elevation by suppressing angiotensin converting enzyme upon high-altitude exposure.
    Li HJ; Zheng CR; Chen GZ; Qin J; Zhang JH; Yu J; Zhang EH; Huang L
    J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316653867. PubMed ID: 27317302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
    Ellsworth AJ; Meyer EF; Larson EB
    West J Med; 1991 Mar; 154(3):289-93. PubMed ID: 2028586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of respiratory inhaled drugs on the prevention of acute mountain sickness.
    Wang X; Chen H; Li R; Fu W; Yao C
    Medicine (Baltimore); 2018 Aug; 97(32):e11788. PubMed ID: 30095637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559 m.
    Berger MM; Macholz F; Sareban M; Schmidt P; Fried S; Dankl D; Niebauer J; Bärtsch P; Mairbäurl H
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890439
    [No Abstract]   [Full Text] [Related]  

  • 12. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories.
    Lipman GS; Kanaan NC; Holck PS; Constance BB; Gertsch JH;
    Ann Emerg Med; 2012 Jun; 59(6):484-90. PubMed ID: 22440488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial.
    Baillie JK; Thompson AA; Irving JB; Bates MG; Sutherland AI; Macnee W; Maxwell SR; Webb DJ
    QJM; 2009 May; 102(5):341-8. PubMed ID: 19273551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone in the treatment of acute mountain sickness.
    Levine BD; Yoshimura K; Kobayashi T; Fukushima M; Shibamoto T; Ueda G
    N Engl J Med; 1989 Dec; 321(25):1707-13. PubMed ID: 2687688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acute mountain sickness by dexamethasone.
    Johnson TS; Rock PB; Fulco CS; Trad LA; Spark RF; Maher JT
    N Engl J Med; 1984 Mar; 310(11):683-6. PubMed ID: 6700643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
    Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
    High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled budesonide for acute mountain sickness.
    Naeije R; Swenson ER
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28890440
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhaled Budesonide Does Not Affect Hypoxic Pulmonary Vasoconstriction at 4559 Meters of Altitude.
    Berger MM; Macholz F; Schmidt P; Fried S; Perz T; Dankl D; Niebauer J; Bärtsch P; Mairbäurl H; Sareban M
    High Alt Med Biol; 2018 Mar; 19(1):52-59. PubMed ID: 29298124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.